m+Medelevator.RU
← Поиск публикаций
Journal of hazardous materials · 2026

Combined effects of extreme heat and NO2 on liver disease progression of T2DM mice.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Qiao Zipeng, Wang Fèlix Faming, Feng Xiangling, Lu Chan

Аннотация

Extreme hot temperature and heavy traffic pollution are increasingly prevalent environmental stressors and are independently associated with adverse metabolic outcomes, but their combined effects on metabolically-associated liver disease (MASLD) in type 2 diabetes mellitus (T2DM) remain unclear. This study employed a T2DM mouse model exposed to 4 h of daily extreme heat at 40°C and nitrogen dioxide with 5 ppm during six weeks in order to assess their interaction in relation to MASLD development. Results showed that combined exposure raised blood glucose levels and aggravated hepatic histopathological damage in T2DM mice. Combined exposure increased lipid peroxidation, as indicated by elevated oxidative stress markers (MDA), while antioxidant markers (CAT, SOD, GSH-PX) were reduced. Inflammatory factors (TNF-α, IL-1β, IL-6, and NF-κB) were significantly upregulated, and immune balance was disrupted (IL-4/IFN-γ ratio). Intestinal permeability increased, with alterations in gut microbiota composition. Mechanistically, these changes were associated with impaired hepatic autophagy, endoplasmic reticulum stress, and ferroptosis-related pathways, leading to accelerated MASLD progression. Capsazepine (CZP) alleviated liver injury by reducing inflammation, oxidative stress, and restoring cellular pathways. This study provides a potential strategy for early prevention and management of MASLD in T2DM.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты